Some Shareholders Feeling Restless Over Bio-View Ltd's (TLV:BIOV) P/E Ratio
Dec 19
Have your own idea? Try our Stock Screener
Israeli (TA) Healthcare Sector Analysis
UpdatedDec 19, 2024
DataAggregated Company Financials
Companies45
- 7D-0.9%
- 3M8.5%
- 1Y6.4%
- YTD4.3%
Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by declines in Kamada and Mediterranean Towers of 4.9% and 4.2%, respectively. Meanwhile, Epitomee Medical actually outperformed within the industry, gaining 24% in the last week. Over the past 12 months, the industry was up 9.1%. As for the next few years, earnings are expected to grow by 35% per annum.
Sector Valuation and Performance
Has the Israeli Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 19 Dec 2024 | ₪9.3b | ₪5.9b | -₪148,524,791.80 | 16.3x | -62.8x | 1.6x |
| Sat, 16 Nov 2024 | ₪8.8b | ₪5.8b | -₪264,823,562.50 | 14.3x | -33.4x | 1.5x |
| Mon, 14 Oct 2024 | ₪8.4b | ₪5.8b | -₪276,912,371.30 | 13.8x | -30.5x | 1.4x |
| Wed, 11 Sep 2024 | ₪8.4b | ₪5.8b | -₪321,860,713.30 | 13.9x | -25.9x | 1.4x |
| Fri, 09 Aug 2024 | ₪8.2b | ₪5.9b | -₪451,681,950.00 | 16.4x | -18.3x | 1.4x |
| Sun, 07 Jul 2024 | ₪8.1b | ₪5.8b | -₪462,090,928.50 | 16x | -17.4x | 1.4x |
| Tue, 04 Jun 2024 | ₪8.4b | ₪5.7b | -₪452,146,055.90 | 19.3x | -18.6x | 1.5x |
| Thu, 02 May 2024 | ₪8.5b | ₪5.7b | -₪518,722,236.50 | 21.2x | -16.3x | 1.5x |
| Sat, 30 Mar 2024 | ₪8.9b | ₪5.7b | -₪449,075,165.60 | 19.1x | -19.8x | 1.6x |
| Mon, 26 Feb 2024 | ₪9.0b | ₪5.6b | -₪486,974,082.60 | 19x | -18.5x | 1.6x |
| Wed, 24 Jan 2024 | ₪8.8b | ₪5.7b | -₪594,262,362.00 | 16.4x | -14.8x | 1.5x |
| Fri, 22 Dec 2023 | ₪8.6b | ₪5.7b | -₪568,021,318.00 | 15.2x | -15.1x | 1.5x |
| Sun, 19 Nov 2023 | ₪8.2b | ₪5.6b | -₪537,693,083.00 | 13.3x | -15.3x | 1.5x |
| Tue, 17 Oct 2023 | ₪8.1b | ₪5.6b | -₪626,917,252.00 | 13.3x | -12.8x | 1.4x |
| Thu, 14 Sep 2023 | ₪8.8b | ₪5.6b | -₪561,742,341.00 | 13.4x | -15.7x | 1.6x |
| Sat, 12 Aug 2023 | ₪8.4b | ₪5.4b | -₪550,844,672.00 | 12.4x | -15.3x | 1.6x |
| Mon, 10 Jul 2023 | ₪8.1b | ₪5.4b | -₪562,768,585.00 | 10.3x | -14.4x | 1.5x |
| Wed, 07 Jun 2023 | ₪8.1b | ₪5.4b | -₪534,040,702.00 | 11.4x | -15.1x | 1.5x |
| Fri, 05 May 2023 | ₪8.1b | ₪5.3b | -₪471,775,326.00 | 9.2x | -17.2x | 1.5x |
| Sun, 02 Apr 2023 | ₪7.9b | ₪5.4b | -₪567,919,785.00 | 9.6x | -14x | 1.5x |
| Tue, 28 Feb 2023 | ₪8.0b | ₪5.1b | -₪380,663,699.00 | 8.8x | -20.9x | 1.6x |
| Thu, 26 Jan 2023 | ₪9.2b | ₪5.0b | -₪327,767,790.00 | 11.7x | -28x | 1.8x |
| Sat, 24 Dec 2022 | ₪9.1b | ₪5.0b | -₪350,943,666.00 | 10.3x | -26x | 1.8x |
| Mon, 21 Nov 2022 | ₪10.1b | ₪5.0b | -₪291,337,978.00 | 9.3x | -34.8x | 2x |
| Wed, 19 Oct 2022 | ₪10.7b | ₪5.0b | -₪288,742,838.00 | 9.3x | -37.2x | 2.2x |
| Fri, 16 Sep 2022 | ₪11.1b | ₪5.1b | -₪233,497,325.00 | 13x | -47.7x | 2.2x |
| Sun, 14 Aug 2022 | ₪13.0b | ₪5.0b | -₪123,484,217.00 | 12.2x | -105.1x | 2.6x |
| Tue, 12 Jul 2022 | ₪12.5b | ₪5.0b | -₪153,543,896.00 | 12.2x | -81.2x | 2.5x |
| Thu, 09 Jun 2022 | ₪12.7b | ₪5.0b | -₪141,130,970.00 | 12.1x | -90.2x | 2.6x |
| Sat, 07 May 2022 | ₪13.9b | ₪4.9b | -₪263,784,936.00 | 16x | -52.8x | 2.9x |
| Mon, 04 Apr 2022 | ₪15.4b | ₪4.9b | -₪137,649,881.00 | 17.9x | -111.9x | 3.2x |
| Wed, 02 Mar 2022 | ₪17.1b | ₪4.9b | -₪252,567,640.00 | 31.2x | -67.8x | 3.5x |
| Fri, 28 Jan 2022 | ₪17.3b | ₪4.9b | -₪234,820,561.00 | 30.1x | -73.7x | 3.6x |
| Sun, 26 Dec 2021 | ₪17.0b | ₪4.8b | -₪301,067,753.00 | 36.2x | -56.4x | 3.5x |
Price to Earnings Ratio
-56.4x
Current Industry PE
- Investors are pessimistic on the Israeli Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have improved over the last three years.
- Revenues for these companies have grown 7.0% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare sector?
| IL Market | 0.24% | |
| Healthcare | -0.94% | |
| Pharma | 1.76% | |
| Healthtech | 0% | |
| Healthcare Services | -0.093% | |
| Life Sciences | -1.24% | |
| Medical Equipment | -1.29% | |
| Biotech | -3.39% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 10.9x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 64% over the next 5 years.
- This is better than its past earnings decline of 58% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 22% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NVLG Novolog (Pharm-Up 1966) | ₪1.81 | 6.9% +₪59.8m | 22.0% | PS0.5x | |
| EPIT Epitomee Medical | ₪10.60 | 16.3% +₪44.0m | 157.9% | PE32.7x | |
| GOHO Golden House | ₪24.00 | 4.3% +₪15.5m | 52.8% | PE7.3x | |
| INCR InterCure | ₪5.17 | 4.5% +₪10.1m | 9.9% | PS0.9x | |
| EMITF-M Elbit Imaging | ₪5.30 | 9.4% +₪4.9m | 33.7% | PS171.8x |
